Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

25.45
+0.70002.83%
Post-market: 25.450.00000.00%16:23 EDT
Volume:296.73K
Turnover:7.49M
Market Cap:699.90M
PE:-9.47
High:25.77
Open:25.17
Low:24.78
Close:24.75
Loading ...

Press Release: HLS Therapeutics Announces Fiscal 2024 Financial Results and Normal Course Issuer Bid

Dow Jones
·
13 Mar

Press Release: HLS Therapeutics Appoints Christine Elliott to its Board of Directors

Dow Jones
·
13 Mar

AlloVir Shareholders Approve Merger With Kalaris Therapeutics

MT Newswires Live
·
13 Mar

Strategic Growth and Financial Positioning: Arcturus Therapeutics’ Promising Outlook Amid Upcoming Trial Data and Financial Adjustments

TIPRANKS
·
13 Mar

Zydus Lifesciences' Venture Capital Arm Investing in Illexcor Therapeutics

MT Newswires Live
·
13 Mar

Dianthus Therapeutics Reports 2024 Financial Results and Clinical Progress

TIPRANKS
·
13 Mar

Nuvation Bio Positioned for Growth with Key Therapeutics and Strategic Leadership

TIPRANKS
·
12 Mar

Cutia Therapeutics Schedules Board Meeting to Approve Annual Results

TIPRANKS
·
12 Mar

Mineralys Therapeutics Prices $175 Million Share Offering

MT Newswires Live
·
12 Mar

Aligos Therapeutics Faces Challenges in Developing Hepatitis B Treatments Amidst Industry Competition

TIPRANKS
·
12 Mar

Werewolf Therapeutics Faces Geopolitical Risks Amid Changing Trade Policies with China

TIPRANKS
·
12 Mar

Lineage Cell Therapeutics Faces Uncertainty Amid New U.S. Administration’s Policies

TIPRANKS
·
12 Mar

Ovid Therapeutics’ Cybersecurity Challenges: Navigating IT Risks and Third-Party Dependencies

TIPRANKS
·
12 Mar

Onkure Therapeutics Faces Stiff Competition in the Pharmaceutical Sector: Challenges in Commercializing PI3Ka Therapies

TIPRANKS
·
12 Mar

Rapport Therapeutics Reports 2024 Financial Results and Progress

TIPRANKS
·
12 Mar

Xilio Therapeutics Reports 2024 Financial Results and Pipeline Progress

TIPRANKS
·
12 Mar